26S Proteasome α Antibodies

Santa Cruz Biotechnology offers a broad range of 26S Proteasome α monoclonal antibodies for research in protein degradation and cellular regulation. 26S Proteasome α Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The 26S proteasome functions as a central component in the ubiquitin-proteasome pathway, degrading ubiquitinated proteins and regulating numerous cellular processes, including the cell cycle, apoptosis, and responses to oxidative stress. By maintaining protein homeostasis, the 26S proteasome is essential for cellular health and function. Understanding 26S proteasome activity provides valuable insights into various diseases, including cancer and neurodegenerative disorders. Researchers can explore protein degradation pathways using specific detection methods optimized for different experimental approaches. Advanced visualization techniques allow for detailed analysis of 26S proteasome localization and activity within cellular compartments. Investigating protein turnover mechanisms helps reveal regulatory networks in both normal and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies targeting the 26S Proteasome α support breakthrough discoveries in protein degradation research and therapeutic development.